Capricorn Fund Managers’s 10x Genomics TXG Stock Holding History

Capricorn Fund Managers’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-101,800	Closed	-$2.16M	–	212
2026 Q1	$2.16M	Buy	+101,800	New	+$2.04M	0.34%	71
2023 Q1	–	Sell	-15,000	Closed	-$547K	–	118
2022 Q4	$547K	Sell	15,000 -10,000	-40%	-$327K	0.14%	76
2022 Q3	$712K	Hold	25,000	–	–	0.22%	73
2022 Q2	$1.13M	Hold	25,000	–	–	0.21%	74
2022 Q1	$1.9M	Buy	+25,000	New	+$2.19M	0.46%	58

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capricorn Fund Managers's TXG Position: Q2 2026 in Review

Capricorn Fund Managers sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 101,800 shares — an estimated $2.16M sold.

Capricorn Fund Managers first reported a position in TXG in Q1 2022 and held it in 5 quarters. The position peaked at $2.16M in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Capricorn Fund Managers reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
Capricorn Fund Managers sold 101,800 10x Genomics shares in Q2 2026, an estimated $2.16M.
Capricorn Fund Managers first reported a position in 10x Genomics in Q1 2022 and held it in 5 quarters.
Capricorn Fund Managers's 10x Genomics position peaked at $2.16M in Q1 2026.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.